To view the PDF file, sign up for a MySharenet subscription.

ASCENDIS HEALTH LIMITED - Dealings in securities by directors

Release Date: 22/10/2015 13:15
Code(s): ASC     PDF:  
Wrap Text
Dealings in securities by directors

ASCENDIS HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
ISIN: ZAE000185005 Share code: ASC
(“Ascendis”)

Dealings in securities by directors

In terms of paragraphs 3.63 to 3.65 of the JSE Limited (“the JSE”) Listings Requirements ("the Listings
Requirements"), the following information, relating to dealings in securities by directors, is disclosed:


Directors:                             Gary Shayne and Crispian Dillon

Nature of the transaction:             As a consequence of their indirect beneficial interest
                                       in Ascendis held through Gane Holdings Proprietary
                                       Limited (“Gane Holdings”), in which Gary Shayne has
                                       a 85% indirect beneficial interest and Crispian Dillon
                                       has a 15% indirect beneficial interest, certain option
                                       agreements pertaining to Ascendis acquisitions are
                                       required to be disclosed as dealings in securities by
                                       these directors.

                                       Prior to the listing of Ascendis on 22 November 2013
                                       (“Listing”), Ascendis acquired companies (“Acquired
                                       Companies”) on the basis that a portion of the total
                                       purchase consideration is settled by way of Ascendis
                                       ordinary shares (“Ascendis Shares”) on a deferred
                                       basis. In order to provide the vendors of the Acquired
                                       Companies (“Vendors”) with the required certainty
                                       regarding the rand value of the listed Ascendis Shares
                                       at the future negotiated date, Gane Holdings entered
                                       into a separate arm’s length option agreements
                                       (“Option Agreements”) directly with the Vendors.

                                       This directors dealings announcement relates to two
                                       Acquisitions that were concluded prior to Listing in
                                       which the Vendors entered into Option Agreements.
                                       The Option Agreements are structured slightly
                                       differently with each Vendor. In the one Option
                                       Agreement the guaranteed return offered to the
                                       Vendor is measured in relation to the performance of
                                       the Acquired Company relative to the performance of
                                       the Ascendis Share price over a specified period. To
                                       the extent the Acquired Company produces returns
                                       exceeding the hurdle return as agreed upon, there will
                                       be a transfer of a set number of Ascendis Shares from
                                       Gane Holdings to the respective Vendors at a nominal
                                       price. In the other Option Agreement the guaranteed
                                       return offered to the Vendor is in the form of an
                                       agreed amount which is settled by Gane Holdings.

                                       No fees are payable by Ascendis to Gane Holdings for
                                       this agreement and there are no financial implications
                                       for Ascendis as a result of this agreement.

Total number of Shares:                172,316

Value per share                        R0

Total transaction price at the         R200
nominal value

Date of transaction                    22 October 2015

Class of shares                        Ordinary Shares

Transaction type                       Sale, off market

Extent of interest:                    Indirect beneficial, through Gane Holdings, in which
                                       Gary Shayne has an 85% indirect beneficial interest
                                       and Crispian Dillon has a 15% indirect beneficial
                                       interest.

Written clearance obtained:            Clearance was obtained from the Chairman.



22 October 2015
Johannesburg

Sponsor
Investec Bank Limited

Date: 22/10/2015 01:15:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story